| 1 |
Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem [J]. Best Pract Res Clin Haematol, 2012, 25(3): 235-242.
|
| 2 |
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e278S-e325S.
|
| 3 |
Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry [J]. J Bone Joint Surg Br, 2007, 89(6): 799-807.
|
| 4 |
Coiteux I, Mazzolai L. [Deep vein thrombosis: epidemiology, risk factors and natural history] [J]. Praxis (Bern 1994), 2006, 95(12): 455-459.
|
| 5 |
Anderson FJ, Spencer FA. Risk factors for venous thromboembolism [J]. Circulation, 2003, 107(23 Suppl 1): I9-I16.
|
| 6 |
Haentjens P, De Groote K, Annemans L. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis [J]. Arch Orthop Trauma Surg, 2004, 124(8): 507-517.
|
| 7 |
Kolb G, Bodamer I, Galster H, et al. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin Certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients [J]. Thromb Haemost, 2003, 90(6): 1100-1105.
|
| 8 |
Fuji T, Ochi T, Niwa S, et al. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin [J]. J Orthop Sci, 2008, 13(5): 442-451.
|
| 9 |
Randelli F, Romanini E, Biggi F, et al. II Italian intersociety consensus statement on antithrombotic prophylaxis in orthopaedics and traumatology: arthroscopy, traumatology, leg immobilization, minor orthopaedic procedures and spine surgery [J]. J Orthop Traumatol, 2013, 14(1): 1-13.
|
| 10 |
National CGCA, Chronic CUK. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital [M]. London: Royal College of Physicians, 2010.
|
| 11 |
Randelli F, Cimminiello C, Capozzi M, et al. Real Life thromboprophylaxis in orthopedic surgery in Italy. Results of the Giotto study [J]. Thromb Res, 2016, 137: 103-107.
|
| 12 |
Farfan M, Bautista M, Bonilla G, et al. Worldwide adherence to ACCP guidelines for thromboprophylaxis after major orthopedic surgery: A systematic review of the literature and meta-analysis [J]. Thromb Res, 2016, 141: 163-170.
|
| 13 |
Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients - Findings from the International medical prevention registry on venous thromboembolism [J]. Chest, 2007, 132(3): 936-945.
|
| 14 |
Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited [J]. Lancet, 2009, 373(9658): 155-166.
|
| 15 |
Caprini JA. Thrombosis risk assessment as a guide to quality patient care [J]. Dis Mon, 2005, 51(2/3): 70-78.
|
| 16 |
Autar R. Nursing assessment of clients at risk of deep vein thrombosis (DVT): the Autar DVT scale [J]. J Adv Nurs, 1996, 23(4): 763-770.
|
| 17 |
Kang J, Jiang X, Wu B. Analysis of risk factors for lower-limb deep venous thrombosis in old patients after knee arthroplasty [J]. Chin Med J, 2015, 128(10): 1358-1362.
|
| 18 |
Edmonds MJ, Crichton TJ, Runciman WB, et al. Evidence-based risk factors for postoperative deep vein thrombosis [J]. ANZ J Surg, 2004, 74(12): 1082-1097.
|
| 19 |
Bagaria V, Modi N, Panghate A, et al. Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study [J]. Postgrad Med J, 2006, 82(964): 136-139.
|
| 20 |
Büyükyılmaz F, Şendir M, Autar R, et al. Risk level analysis for deep vein thrombosis (DVT): A study of Turkish patients undergoing major orthopedic surgery [J]. J Vasc Nurs, 2015, 33(3): 100-105.
|
| 21 |
Deitelzweig SB, Mckean SC, Amin AN, et al. Prevention of venous thromboembolism in the orthopedic surgery patient [J]. Cleve Clin J Med, 2008, 75(Suppl 3): S27-S36.
|
| 22 |
Piazza G, Seddighzadeh A, Goldhaber SZ. Deep-vein thrombosis in the elderly [J]. Clin Appl Thromb Hemost, 2008, 14(4): 393-398.
|
| 23 |
Gao Y, Long A, Xie Z, et al. The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery [J]. Springerplus, 2016, 5(1): 1362.
|
| 24 |
Ishimaru D, Ogawa H, Maeda M, et al. Outcomes of elderly patients with proximal femoral fractures according to positive criteria for surgical treatment [J]. Orthopedics, 2012, 35(3): e353-e358.
|
| 25 |
Magetsari R, Dewo P, Nugroho AS, et al. Deep vein thrombosis in elderly patients following surgery for fracture of the proximal femur [J]. Malays Orthop J, 2014, 8(3): 7-10.
|
| 26 |
Lieberman DV, Lieberman D. Proximal deep vein thrombosis after hip fracture surgery in elderly patients despite thromboprophylaxis [J]. Am J Phys Med Rehabil, 2002, 81(10): 745-750.
|
| 27 |
Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I [J]. Arthritis Rheum, 2008, 58(1): 15-25.
|
| 28 |
Hamilton WG, Reeves JD, Fricka KB, et al. Mechanical thromboembolic prophylaxis with risk stratification in total knee arthroplasty [J]. J Arthroplasty, 2015, 30(1): 43-45.
|
| 29 |
Sasaki K, Miura H, Takasugi S, et al. Venous hemodynamic alterations in lower limbs undergoing total joint arthroplasty [J]. Am J Orthop (Belle Mead NJ), 2009, 38(8): E137-E140.
|
| 30 |
Krueger A, Bliemel C, Zettl R, et al. Management of pulmonary cement embolism after percutaneous vertebroplasty and kyphoplasty: a systematic review of the literature [J]. Eur Spine J, 2009, 18(9): 1257-1265.
|
| 31 |
Shaikh N, Parchani A, Bhat V, et al. Fat embolism syndrome: clinical and imaging considerations: case report and review of literature [J]. Indian J Crit Care Med, 2008, 12(1): 32-36.
|
| 32 |
Sigel B, Edelstein AL, Felix WR, et al. Compression of the deep venous system of the lower leg during inactive recumbency [J]. Arch Surg, 1973, 106(1): 38-43.
|
| 33 |
Holderness BM, Goto Y, Mckernan L, et al. Thromboprophylaxis and outcomes for total joint arthroplasty in congenital bleeding disorders: a Single-Center experience [J]. Clin Appl Thromb Hemost, 2016, 22(6): 563-568.
|
| 34 |
Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e120S-e151S.
|
| 35 |
Paiement GD, Wessinger SJ, Harris WH. Survey of prophylaxis against venous thromboembolism in adults undergoing hip surgery[J]. Clin Orthop Relat Res, 1987 (223): 188-193.
|
| 36 |
Leyvraz PF, Bachmann F, Hoek J, et al. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin [J]. BMJ, 1991, 303(682): 543-548.
|
| 37 |
Turpie AG, Bauer KA, Eriksson BI, et al. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points [J]. Chest, 2004, 126(2): 501-508.
|
| 38 |
Miggiano GA, Robilotta L. Vitamin K-controlled diet: problems and prospects [J]. Clin Ter, 2005, 156(1/2): 41-46.
|
| 39 |
Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation [J]. Blood, 1990, 75(9): 1753-1762.
|
| 40 |
Priebe HJ. Triggers of perioperative myocardial ischaemia and infarction [J]. Br J Anaesth, 2004, 93(1): 9-20.
|
| 41 |
Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction [J]. Br J Anaesth, 2007, 99(3): 316-328.
|
| 42 |
Lassen MR, Haas S, Kreutz R, et al. Rivaroxaban for thromboprophylaxis after Fracture-Related orthopedic surgery in routine clinical practice [J]. Clin Appl Thromb Hemost, 2016, 22(2): 138-146.
|
| 43 |
Rath NK, Goodson MW, White SP, et al. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement [J]. Knee, 2013, 20(6): 397-400.
|